Physician profile
Sam Mikhail
NPI 1245511476
$178.81
in general payments reported to CMS, 2019-2025
8 companies · $14.35 in 2025
The $14.35 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.36 · 2020: $11.55 · 2022: $15.81 · 2023: $50.74 · 2025: $14.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $65.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $65.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $35.05 | 2019 | |
| Merck Sharp & Dohme LLC | $30.01 | 2019 | |
| Novo Nordisk INC | $29.36 | 2022-2023 | Wegovy |
| Gilead Sciences, INC. | $21.30 | 2019 | |
| Urgo Medical North America, LLC | $20.20 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Organon LLC | $16.99 | 2023 | Nexplanon |
| Astrazeneca Pharmaceuticals LP | $14.35 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Mikhail listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.